• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why BSQUARE Shares Are Trading Higher By Around 44%; Here Are 20 Stocks Moving Premarket

    10/12/23 9:29:34 AM ET
    $AGIL
    $ATPC
    $BIOC
    $BSQR
    Professional Services
    Consumer Discretionary
    Medical/Nursing Services
    Health Care
    Get the next $AGIL alert in real time by email

    Gainers

    OpGen, Inc. (NASDAQ:OPGN) shares rose 432% to $1.79 in pre-market trading. Opgen said on Oct. 6, unit Curetis GMBH received payment of 750,000 euros related to the sale of certain Unyvero A50 Systems by Curetis to a strategic partner.

    Secoo Holding Limited (NASDAQ:SECO) shares gained 465% to $1.81 in pre-market trading after gaining around 12% on Wednesday.

    ReShape Lifesciences Inc. (NASDAQ:RSLS) shares rose 211% to $0.84 in pre-market trading. ReShape Lifesciences was granted U.S. patent #11779482 for "Intragrastric Device for Treating Obesity."

    Jaguar Health, Inc. (NASDAQ:JAGX) shares climbed 74.2% to $0.4215 in pre-market trading, after gaining over 3% on Wednesday.

    BSQUARE Corporation (NASDAQ:BSQR) rose 44.4% to $1.79 in pre-market trading. Kontron America agreed to acquire BSQUARE for $1.90 per share in an all-cash transaction, representing an implied equity value of $38 million.

    Versus Systems Inc. (NASDAQ:VS) shares jumped 43.6% to $0.3096 in pre-market trading after gaining around 7% on Wednesday.

    Lixiang Education Holding Co., Ltd. (NASDAQ:LXEH) rose 32% to $0.32 in pre-market trading.

    Biocept, Inc. (NASDAQ:BIOC) gained 30.9% to $1.22 in pre-market trading, after falling around 9% on Wednesday.

    Taoping Inc. (NASDAQ:TAOP) shares surged 12.4% to $2.26 in pre-market trading after falling 4% on Wednesday. Taoping recently reported a narrower loss for H1.

    Jayud Global Logistics Limited (NASDAQ:JYD) shares rose 23% to $2.25 in pre-market trading.

    Losers

    Tempest Therapeutics, Inc (NASDAQ:TPST) fell 30.4% to $6.80 in pre-market trading. Tempest Therapeutics shares jumped 2,879% on Wednesday, the company released new data demonstrating superiority of TPST-1120 arm across multiple study endpoints in first-line hepatocellular carcinoma study.

    Agape ATP Corporation (NASDAQ:ATPC) shares fell 28.6% to $1.30 in pre-market trading, after dipping 46% on Wednesday.

    Phio Pharmaceuticals Corp. (NASDAQ:PHIO) fell 27.3% to $1.89 in pre-market trading. Phio Pharmaceuticals shares surged 91% on Wednesday after the company announced the poster presentation of two key preclinical studies of its INTASYL compound PH-894 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics.

    Wheeler Real Estate Investment Trust, Inc. (NASDAQ:WHLR) shares fell 23.7% to $1.03 in pre-market trading after jumping around 52% on Wednesday.

    Clearmind Medicine Inc. (NASDAQ:CMND) fell 22.2% to $0.1761 in pre-market trading, after surging 50% on Wednesday.

    Gaucho Group Holdings, Inc. (NASDAQ:VINO) fell 19.5% to $0.8692 in pre-market, after jumping 21% on Wednesday.

    AgileThought, Inc. (NASDAQ:AGIL) fell 17.1% to $0.1509 in pre-market trading, after gaining 23% on Wednesday.

    Safe and Green Development Corporation (NASDAQ:SGD) shares fell 14.1% to $1.16 in pre-market trading, after declining around 3% on Wednesday.

    Freight Technologies, Inc. (NASDAQ:FRGT) shares fell 13.8% to $0.31 in pre-market trading, after declining 5% on Wednesday.

    Maris-Tech Ltd. (NASDAQ:MTEK) shares fell 12% to $0.9060 in pre-market trading, after declining 10% on Wednesday.

    Now Read This: Walgreens, Delta Air Lines And 3 Stocks To Watch Heading Into Thursday

    Get the next $AGIL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AGIL
    $ATPC
    $BIOC
    $BSQR

    CompanyDatePrice TargetRatingAnalyst
    Tempest Therapeutics Inc.
    $TPST
    1/22/2026$11.00Neutral → Buy
    H.C. Wainwright
    Phio Pharmaceuticals Corp.
    $PHIO
    6/5/2025$14.00Buy
    H.C. Wainwright
    Tempest Therapeutics Inc.
    $TPST
    4/10/2025Sector Outperform → Sector Perform
    Scotiabank
    Tempest Therapeutics Inc.
    $TPST
    4/10/2025Buy → Neutral
    H.C. Wainwright
    Tempest Therapeutics Inc.
    $TPST
    3/14/2024$13.00Sector Outperform
    Scotiabank
    Tempest Therapeutics Inc.
    $TPST
    2/8/2024$15.00Buy
    Jefferies
    AgileThought Inc.
    $AGIL
    12/9/2022$7.00Buy
    Canaccord Genuity
    Versus Systems Inc.
    $VS
    12/7/2022$2.00Buy → Neutral
    H.C. Wainwright
    More analyst ratings

    $AGIL
    $ATPC
    $BIOC
    $BSQR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Tempest Therapeutics upgraded by H.C. Wainwright with a new price target

    H.C. Wainwright upgraded Tempest Therapeutics from Neutral to Buy and set a new price target of $11.00

    1/22/26 8:24:05 AM ET
    $TPST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    H.C. Wainwright resumed coverage on Phio Pharmaceuticals with a new price target

    H.C. Wainwright resumed coverage of Phio Pharmaceuticals with a rating of Buy and set a new price target of $14.00

    6/5/25 7:35:43 AM ET
    $PHIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Tempest Therapeutics downgraded by Scotiabank

    Scotiabank downgraded Tempest Therapeutics from Sector Outperform to Sector Perform

    4/10/25 8:50:49 AM ET
    $TPST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGIL
    $ATPC
    $BIOC
    $BSQR
    SEC Filings

    View All

    SEC Form D filed by Tempest Therapeutics Inc.

    D - Tempest Therapeutics, Inc. (0001544227) (Filer)

    4/3/26 2:28:03 PM ET
    $TPST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by Freight Technologies Inc.

    6-K - Freight Technologies, Inc. (0001687542) (Filer)

    4/2/26 6:40:04 AM ET
    $FRGT
    Professional Services
    Consumer Discretionary

    SEC Form S-3 filed by Tempest Therapeutics Inc.

    S-3 - Tempest Therapeutics, Inc. (0001544227) (Filer)

    4/1/26 9:50:03 PM ET
    $TPST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGIL
    $ATPC
    $BIOC
    $BSQR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chairman, Pres. & CEO Bitterman Robert J bought $5,150 worth of shares (5,000 units at $1.03), increasing direct ownership by 2% to 291,421 units (SEC Form 4)

    4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)

    1/2/26 4:05:06 PM ET
    $PHIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chairman, Pres. & CEO Bitterman Robert J bought $5,100 worth of shares (5,000 units at $1.02), increasing direct ownership by 2% to 286,421 units (SEC Form 4)

    4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)

    12/29/25 8:10:21 AM ET
    $PHIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chairman, Pres. & CEO Bitterman Robert J bought $5,700 worth of shares (5,000 units at $1.14), increasing direct ownership by 2% to 281,421 units (SEC Form 4)

    4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)

    11/24/25 12:54:10 PM ET
    $PHIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGIL
    $ATPC
    $BIOC
    $BSQR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Freight Technologies Announces Strategic Update on Transition to AI-Powered, Software-First Logistics Technology Company

    HOUSTON, April 02, 2026 (GLOBE NEWSWIRE) -- Freight Technologies, Inc. (NASDAQ:FRGT, ", Fr8Tech", or the ", Company", )), a technology-centric logistics company offering a diversified portfolio of AI software solutions designed to address key inefficiencies in the supply chain, today announced progress in its transformation from an OTR online freight broker to a software-first, AI-native logistics technology company. As part of the Company's strategic transition, the Company also announced that it is exploring strategic alternatives for its online brokerage operations, including its potential sale, and has engaged with multiple interested parties as part of that process. The Company's Boar

    4/2/26 6:30:00 AM ET
    $FRGT
    Professional Services
    Consumer Discretionary

    Lixiang Education Announces Plan to Implement ADS Ratio Change

    LISHUI, China, April 01, 2026 (GLOBE NEWSWIRE) -- Lixiang Education Holding Co., Ltd. (NASDAQ:LXEH), a prestigious private education service provider in China, today announced that it plans to change the ratio of its American depositary shares ("ADSs") to its ordinary shares (the "ADS Ratio"), par value US$0.0001 per share, from the current ADS Ratio of one (1) ADS to one hundred (100) ordinary shares to a new ADS Ratio of one (1) ADS to one thousand (1,000) ordinary shares (the "ADS Ratio Change"). The Company anticipates that the ADS Ratio Change will be effective on or about April 20, 2026 (the "Effective Date"). For the Company's ADS holders, the change in the ADS Ratio will have the

    4/1/26 5:00:00 PM ET
    $LXEH
    Other Consumer Services
    Real Estate

    SIDUS SPACE REPORTS FULL-YEAR 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATES

    CAPE CANAVERAL, Fla., April 1, 2026 /PRNewswire/ -- Sidus Space, Inc. (NASDAQ:SIDU) (the "Company" or "Sidus"), an innovative space and defense technology company, announced its financial results for the fourth quarter and full-year ended December 31, 2025, and provided a business update. "2025 was a pivotal year for Sidus as we continued executing our long‑term strategy to build vertically integrated space and defense technology platforms," said Carol Craig, Founder and CEO of Sidus Space. "We expanded our on‑orbit capabilities with the successful launch and commissioning of Li

    4/1/26 6:01:00 AM ET
    $MTEK
    $SIDU
    Telecommunications Equipment
    Telecommunications

    $AGIL
    $ATPC
    $BIOC
    $BSQR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Trojanowski Justin

    4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)

    4/2/26 5:00:36 PM ET
    $TPST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Maestas Nicholas

    4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)

    4/2/26 5:00:35 PM ET
    $TPST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 3 filed by new insider Gu Zhenhua

    3 - Jayud Global Logistics Ltd (0001938186) (Issuer)

    4/2/26 6:02:47 AM ET
    $JYD
    Integrated Freight & Logistics
    Industrials

    $AGIL
    $ATPC
    $BIOC
    $BSQR
    Leadership Updates

    Live Leadership Updates

    View All

    Phio Pharmaceuticals Announces Participation in Third Annual DealFlow Discovery Conference

    Phio's Presentation to take place on Wednesday January 28, 2026 at 9 AM ETKing of Prussia, Pennsylvania--(Newsfile Corp. - January 26, 2026) - Phio Pharmaceuticals Corp. (NASDAQ:PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio announced today announced that it will participate in the DealFlow Discovery Conference, taking place January 28-29, 2026 at the Borgata Hotel in Atlantic City, NJ.Robert Bitterman, CEO and Chairman of the Board of Phio Pharmaceuticals will deliver a company presentation on January 28th at 9 AM in Borgata Hotel Room #1 and the management team will be avai

    1/26/26 8:15:00 AM ET
    $PHIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    La Rosa Holdings Corp. Announces Appointment of Nicholas Adler as Chairman of the Board and Chairman of the Compensation Committee

    Celebration, FL, Dec. 30, 2025 (GLOBE NEWSWIRE) -- La Rosa Holdings Corp. (NASDAQ: LRHC) ("La Rosa" or the "Company"), a real estate and PropTech company, today announced that the Company's Board of Directors (the "Board") has appointed Mr. Nicholas Adler as a member of the Board, effective December 29, 2025. Upon his appointment, Mr. Adler was also named Chairman of the Board, Chairman of the Compensation Committee, and a member of both the Audit Committee and the Nominating and Corporate Governance Committee. Additionally, on December 29, 2025, Mr. Siamack Alavi notified the Board of his resignation as a director of the Company, effective immediately. Mr. Alavi also stepped down from hi

    12/30/25 8:30:00 AM ET
    $FRGT
    $LRHC
    Professional Services
    Consumer Discretionary
    Real Estate
    Finance

    Freight Technologies Announces the Commercial Launch of Zayren - AI-Powered Freight Rate Prediction & Carrier Matching Platform

    HOUSTON, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Freight Technologies, Inc. (NASDAQ:FRGT, "Fr8Tech" or the "Company")), a logistics management innovation company offering a diverse portfolio of technology-driven solutions, today announced the commercial launch of Zayren, an artificial intelligence ("AI") based, machine learning pricing-prediction tool and carrier-matching platform designed specifically for cross-border and domestic over-the-road ("OTR") freight shipments across Mexico and the United States. Developed by Fr8Tech's in-house AI Lab or the Artificial Intelligence Lab, Zayren provides real-time freight-rate predictions, enabling shippers and brokers to access instant pricing insight

    11/19/25 9:00:00 AM ET
    $FRGT
    Professional Services
    Consumer Discretionary

    $AGIL
    $ATPC
    $BIOC
    $BSQR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Maris-Tech Ltd.

    SC 13G/A - Maris Tech Ltd. (0001872964) (Subject)

    12/13/24 11:34:57 AM ET
    $MTEK
    Telecommunications Equipment
    Telecommunications

    Amendment: SEC Form SC 13D/A filed by Wheeler Real Estate Investment Trust Inc.

    SC 13D/A - Wheeler Real Estate Investment Trust, Inc. (0001527541) (Subject)

    12/9/24 5:54:19 PM ET
    $WHLR
    Real Estate Investment Trusts
    Real Estate

    Amendment: SEC Form SC 13G/A filed by Wheeler Real Estate Investment Trust Inc.

    SC 13G/A - Wheeler Real Estate Investment Trust, Inc. (0001527541) (Subject)

    12/5/24 5:28:41 PM ET
    $WHLR
    Real Estate Investment Trusts
    Real Estate

    $AGIL
    $ATPC
    $BIOC
    $BSQR
    Financials

    Live finance-specific insights

    View All

    SIDUS SPACE REPORTS FULL-YEAR 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATES

    CAPE CANAVERAL, Fla., April 1, 2026 /PRNewswire/ -- Sidus Space, Inc. (NASDAQ:SIDU) (the "Company" or "Sidus"), an innovative space and defense technology company, announced its financial results for the fourth quarter and full-year ended December 31, 2025, and provided a business update. "2025 was a pivotal year for Sidus as we continued executing our long‑term strategy to build vertically integrated space and defense technology platforms," said Carol Craig, Founder and CEO of Sidus Space. "We expanded our on‑orbit capabilities with the successful launch and commissioning of Li

    4/1/26 6:01:00 AM ET
    $MTEK
    $SIDU
    Telecommunications Equipment
    Telecommunications

    Tempest Announces Record Date for Anticipated Dividend Distribution of Warrants to Stockholders

    BRISBANE, Calif., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (NASDAQ:TPST) ("Tempest"), a clinical-stage biotechnology company with a pipeline of targeted and immune-mediated therapeutics to fight cancer, today announced the record date of January 30, 2026 (the "Record Date") for the distribution of warrants to purchase Tempest common stock ("Warrants") as a dividend (the "Warrant Dividends"), as contemplated by Tempest's previously announced Asset Purchase Agreement (the "Asset Purchase Agreement") with Erigen LLC and Factor Bioscience Inc. The distribution of the Warrant Dividends is expected to be Tuesday, February 3, 2026, but is subject to the prior satisfaction of c

    1/20/26 5:20:02 PM ET
    $TPST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Maris-Tech Announces Financial Results for the Six Months Ended June 30, 2025

    The company continues to advance AI-powered video streaming and edge computing solutions for the defense and HLS markets Rehovot, Israel , Sept. 26, 2025 (GLOBE NEWSWIRE) -- Maris-Tech Ltd. (NASDAQ:MTEK, MTEKW)) ("Maris-Tech" or the "Company"), a global leader in video and artificial intelligence ("AI") – based edge computing technology, today announced its financial results for the six months ended June 30, 2025. Revenues for the six-months ended June 30, 2025, were $707,021, compared to $3,410,258 for the same six-month period in 2024. Net loss for the six-months ended June 30, 2025, was $2,388,294, compared to net income of $131,797 for the same six-month period in 2024. Total cas

    9/26/25 4:04:00 PM ET
    $MTEK
    Telecommunications Equipment
    Telecommunications